Table 3.
Reports on secondary osteoporosis.
| Studies | Age (y) | No. of patients | Primary disease | Methodology | Osteopenia n (%) | Osteoporosis n (%) |
|---|---|---|---|---|---|---|
|
| ||||||
| Sadat-Ali et al (2011)25 | 28.4 | 186 | Sickle cell disease | DEXA | 30 (16) | 135 (72.5) |
| Al-Turki H (2009)26 | 27.5 | 35 | Sickle cell disease and pregnancy | DEXA | 14 (39.8) | 21 (65) |
| Al-Amri and Sadat-Ali (2009)27 | 49 | 71 | Postchemotherapy | DEXA | 24 (33.9) | 19 (26.8) |
| Sadat-Ali et al (2008)28 | 30 | 87 | Sickle cell disease | DEXA | 22 (25) | 27 (31) |
| Sadat-Ali et al (2009)29 | 38.3 | 165 | Steroid use | DEXA | 81 (49.1) | 48.3 |
| Sadat-Ali et al (2008)30 | 18 | 32 | Scoliosis | DEXA | 9 (28.1) | 20 (62.5) |
| Sadat-Ali and Al-Elq (2007)31 | 33 | 36 | Sickle cell disease | DEXA | 7 (19.5) | 14 (38.9) |
| Al-Elq and Sadat-Ali (2006)32 | 57.5 | 154 | Diabetes mellitus | DEXA | 80 (52) | 40 (26) |
| Al-Maatouq et al (2004)33 | 55 | 101 | Diabetes mellitus | DEXA | 44 (43.6) | 47 (46.8) |
DEXA: dual-energy x-ray absorptiometry. Age data are mean and standard deviation (when available).